Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Features
LOVO, an artificial intelligence company focused on voice generation, has been hit with a proposed class action lawsuit, with the plaintiff voice actors arguing they have not been properly compensated for the use of their voices.
Features
Given the DOJ's limited tools to prosecute AI crimes where no one intended for the AI to violate the law, effective compliance likely will be the best defense for companies to avoid criminal charges for AI-based crimes.
Features
A steep rise in the use of GenAI and computer-generated influencers brings with it new marketing risks and considerations for celebrities, influencers, and businesses alike.
Features
In the AI edition of the classic "build versus buy" dilemma, some marquee firms have opted to leverage their position as the largest buyers of legal tech to influence vendor development of AI-powered services to suit their needs.
Features
In the AI edition of the classic "build versus buy" dilemma, some marquee firms have opted to leverage their position as the largest buyers of legal tech to influence vendor development of AI-powered services to suit their needs.
Features
Maintaining consistent communication with clients can be time-consuming for most law firm professionals. It requires a substantial commitment of resources to stay informed about recent events and developments relevant to the client's business. The time has never been better for firms to start introducing technology, like AI, to improve their overall business.
Features
As the focus on protecting personal data continues to grow with the ever-widening adoption of artificial intelligence (AI) tools, exponential increases in the number and breadth of data breaches, and growing awareness of the risk posed by data brokers, the time appears right for a U.S. federal data privacy regulation to succeed in Congress. But is the new American Privacy Rights Act that regulation?
Features
This article describes certain key developments in the period from passage of the CHIPS Act through the present day, and provides a brief survey of key grantmaking and investment activity by U.S. government agencies since passage of the Act.
Features
This article explores the benefits and risks of AI-driven drug discovery from the legal perspective. Since the law governing IP rights in AI-driven drug discovery is still in its infant state, any future legal development is likely to have significant implications in many areas.
Features
A statutory predicate to the contractual outcome regarding ownership of patent rights is the requirement of a sufficient contribution by a natural person in the effort that yielded the output. The issues implicated by this requirement are one development among more to come as patent law and policy try to catch up to proliferating AI technology.
